| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/25/2007 | US20070020730 Method for overexpression of zwitterionic polysaccharides |
| 01/25/2007 | US20070020729 Novel collectin |
| 01/25/2007 | US20070020728 Muteins of apolipoprotein D |
| 01/25/2007 | US20070020727 Non-maltogenic glycosidase for improving storage stabilty of baked goods |
| 01/25/2007 | US20070020726 Novel glutaminase, its gene and a method of producing it |
| 01/25/2007 | US20070020725 Prokaryotically produced antibodies and uses thereof |
| 01/25/2007 | US20070020723 Ceramide kinase-like proteins |
| 01/25/2007 | US20070020722 Telomere elongation |
| 01/25/2007 | US20070020714 Biosensor with increased signal intensity to sugar concentration that is a maltose binding protein bound to enhanced cyan, enhanced blue, or enhanced green fluorescent protein on one end and enhanced yellow, enhanced green, or red fluorescent protein on the other through dipeptide linkages |
| 01/25/2007 | US20070020713 Antibodies to the fuel oxygenate mtbe and use thereof in immunoassays |
| 01/25/2007 | US20070020709 IGF binding proteins |
| 01/25/2007 | US20070020708 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition |
| 01/25/2007 | US20070020706 Truncated proteins as cancer markers |
| 01/25/2007 | US20070020698 IGF binding proteins |
| 01/25/2007 | US20070020695 Immunogenic peptide sequences; antibodies directed against particular amino acid regions of Hsp70B' |
| 01/25/2007 | US20070020690 Method for site-specific protein modifications |
| 01/25/2007 | US20070020686 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 01/25/2007 | US20070020685 Secretion of antibodies without signal peptides from bacteria |
| 01/25/2007 | US20070020674 Novel gene defective in APECED and its use |
| 01/25/2007 | US20070020653 DNA polymerase |
| 01/25/2007 | US20070020634 Polynucleotide sequence transcribed from a complementary polynucleotide sequence thereof; glutamyl O-tRNA suppresses in the presence of a tRNA synthetase (RS) selected from Archaeoglobus fulgidus, Methanosarcina mazei synthetase, Methanobacterium thermoautotrophicum, and Pyrococcus horikoshii synthetase |
| 01/25/2007 | US20070020627 Artificial transcription factors |
| 01/25/2007 | US20070020624 Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics |
| 01/25/2007 | US20070020284 decreased protein degradation, increased stability and circulation time; for excess weight, diabetes, high blood lipid level, arteriosclerosis, arterial plaque, the reduction or prevention of gall stones formation, insufficient lean tissue mass, insufficient sensitivity to insulin, and stroke |
| 01/25/2007 | US20070020283 Fusion protein; multimeric protein; treating interferon gamma -related conditions |
| 01/25/2007 | US20070020277 Human Oncogene Induced Secreted Protein I |
| 01/25/2007 | US20070020276 Methods for the treatment of carcinoma |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020270 Human serpin polypeptides |
| 01/25/2007 | US20070020269 Phosphokinase and the usage thereof |
| 01/25/2007 | US20070020268 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020259 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases |
| 01/25/2007 | US20070020257 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 01/25/2007 | US20070020251 Administering to the cell all or part of a peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for inhibiting calcium uptake by a cancer cell |
| 01/25/2007 | US20070020250 Lactic acid bacteria producing Nisin at high concentration and method for selecting the same |
| 01/25/2007 | US20070020235 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | US20070020233 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease |
| 01/25/2007 | CA2616256A1 Genetically modified antibody composition |
| 01/25/2007 | CA2616021A1 Methods to express recombinant proteins from lentiviral vectors |
| 01/25/2007 | CA2615617A1 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
| 01/25/2007 | CA2614811A1 Process for the manufacture of eptifibatide |
| 01/25/2007 | CA2610237A1 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 01/25/2007 | CA2604917A1 Recombinant yeasts for synthesizing epoxide hydrolases |
| 01/24/2007 | EP1746166A1 Process for conducting mixed culturing of microbial host cell strains |
| 01/24/2007 | EP1746165A1 Scalable fermentation process |
| 01/24/2007 | EP1746162A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/24/2007 | EP1746160A2 Hepatocyte growth factor receptor antagonists and uses thereof |
| 01/24/2007 | EP1746157A1 Method of proliferating plasma cell |
| 01/24/2007 | EP1746107A2 Antibody variants and fragments thereof |
| 01/24/2007 | EP1746104A1 Novel soluble cd14 antigen |
| 01/24/2007 | EP1745141A1 O-linked glycoforms of polypeptides and method to manufacture them |
| 01/24/2007 | EP1745128A2 PORCINE FORSSMAN SYNTHETASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
| 01/24/2007 | EP1745072A2 Method for producing soluble mhc proteins |
| 01/24/2007 | EP1744619A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/24/2007 | EP1259627B1 Heterologous expression of neisserial proteins |
| 01/24/2007 | EP1181363B1 Recombinant human mannan-binding lectin |
| 01/24/2007 | EP1180525B1 Transcriptional activation inhibitory protein |
| 01/24/2007 | EP1173572B1 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
| 01/24/2007 | EP1116792B1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 01/24/2007 | EP1032674B1 (chlamydia pneumoniae) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/24/2007 | EP0941341B1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 01/24/2007 | EP0941244B1 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide and a method of detecting auto-immune antibodies |
| 01/24/2007 | EP0760000B1 Alphavirus expression vector |
| 01/24/2007 | EP0758383B1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 01/24/2007 | CN1902321A Method for flocculation of a fermentation broth comprising a fungus |
| 01/24/2007 | CN1902311A Novel recombinant proteins with n-terminal free thiol |
| 01/24/2007 | CN1902231A CD20 antibodies with increased Fc receptor binding affinity and effector function |
| 01/24/2007 | CN1902230A Anti-SARS virus antibody, hybridoma producing the antibody and immunoassay reagent using the antibody |
| 01/24/2007 | CN1902224A Process for purifying interferon beta |
| 01/24/2007 | CN1900303A Process for preparing plant immune globulin and its use |
| 01/24/2007 | CN1900302A Process for biologically synthesizing aspartame |
| 01/24/2007 | CN1900301A Process for producing lactic streptocin using plant cake dregs as raw material |
| 01/24/2007 | CN1900274A Recombinant malignant malarial parasite hypoxanthine-guanine-xanthine phosphoribosyl transferase and its preparing method and use |
| 01/24/2007 | CN1900116A Anti-lymphotoxin-beta receptor antibodies, pharmaceutical composition containing the same and pharmaceutical application thereof |
| 01/24/2007 | CN1899599A Method for preparing Nosiheptide premixed agent |
| 01/24/2007 | CN1899106A Gugan synthetic substance and its preparing method and use |
| 01/24/2007 | CN1296485C Glutamine-auxotroph human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 01/24/2007 | CN1296480C Ligand for regulating exogenic expression through molting hormone receptor complex |
| 01/24/2007 | CN1296478C Cell culture medium |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1295979C Soybean phosphopeptide calcium and method for producing thereof |
| 01/23/2007 | US7166771 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 01/23/2007 | US7166717 Nucleic acids encoding β 1,4-N-acetylgalactosaminyltransferases from C. jejuni |
| 01/23/2007 | US7166714 Polynucleotide encoding a STEAP-1 polypeptide, used for diagnosis and treatment of prostate cancer |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166701 Human survivin interacting protein 1 (SIP-1) |
| 01/23/2007 | US7166700 PRO703 Polypeptides |
| 01/23/2007 | US7166698 Mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 01/23/2007 | US7166697 V-like domain binding molecules |
| 01/23/2007 | US7166692 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 01/23/2007 | US7166577 Albumin having enhanced antimicrobial activity |
| 01/23/2007 | US7166468 Using nucleic acid fragment; expression cassettes; cell libraries; open reading frames |
| 01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
| 01/23/2007 | US7166450 Hyaluronan synthase gene and uses thereof |
| 01/23/2007 | US7166446 Vector with nucleotide sequence that comprises a yeast-recognized transcription and translation initiation and termination region; coding amino acid sequence for hybrid precursor polypeptide linked to heterologous mammalian protein such as platelet derived growth factor; genetic engineering |
| 01/23/2007 | US7166445 Eukaryotic host cell genetically engineered to express a gene for a protein as an extracellular product, and to express IGF(insulin-like growth factor)-1-signaling pathway gene; cell lines in serum-free and/or protein-free and/or peptone-free media |
| 01/23/2007 | US7166444 Nucleic acids encoding chromophores/fluorophores and methods for using the same |
| 01/23/2007 | US7166298 Genetic immunization with cationic lipids |